Evotec, UCB ink management agreement
Evotec has announced an EVT Execute collaboration aimed at providing a complete solution to UCB's global sample management requirements. Evotec will manage UCB's compound collection out of its state-of-the-art sample management facility in Toulouse, France. The agreement covers an initial period of five years.
Dr. Mario Polywka, Chief Operating Officer of Evotec, said, "We are delighted to expand our long-standing and successful relationship with UCB through this collaboration designed to provide sample management infrastructure, logistics and expertise to support their drug discovery efforts. This collaboration will use the first-class team and best-in-class infrastructure from our Toulouse site, which was acquired in April 2015."
Dr. Neil Weir, senior vice president of discovery at UCB, said, "With Evotec's proven track record in compound management coupled with global operations and an outstanding team and facility in Toulouse, we are confident of the quality and scalability of the services our internal and external discovery teams will receive."
No financial details were disclosed.